Alpha Compute (ALP) Revenue (2009 - 2025)
Alpha Compute's (ALP) quarterly Revenue came in at $3.2 million in Q4 2025, up 59.55% quarter-over-quarter from $2.0 million in Q4 2022.
Analysis
Alpha Compute (ALP) Revenue (2009 - 2025) Analysis & Trends
Alpha Compute (ALP) has reported Revenue for 4 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Revenue changed N/A year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $7.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at $97000.0, changed N/A from the prior year.
- Revenue was $3.2 million for Q4 2025 at Alpha Compute, up from $2.0 million in the prior quarter.
- Over five years, Revenue peaked at $3.2 million in Q4 2025 and troughed at $2.0 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.54 Bn | 192.56 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.55 Bn | 176.37 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 131.10 Bn | 123.25 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.62 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.69 Bn | 55.51 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.54 Bn | 48.40 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.80 Bn | 30.52 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Alpha Compute | 39.30 Mn | 39.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.20 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2010 | 1.17 Mn |
| Sep 30, 2010 | 1.35 Mn |
| Dec 31, 2009 | 646,426.55 |
| Sep 30, 2009 | 695,087.14 |
| Jun 30, 2009 | 2,568.49 |
| Mar 31, 2009 | -123,826.01 |